Literature DB >> 17964443

Survival after liver resection for metastatic colorectal carcinoma in a large population.

Shimul A Shah1, Rudy Bromberg, Angela Coates, Eddy Rempel, Marko Simunovic, Steven Gallinger.   

Abstract

BACKGROUND: Previous reports of liver resection for metastatic colorectal cancer (CRC) are typically from single centers and cannot account for selection or referral bias. We measured longterm survival after liver resection for metastatic CRC in the province of Ontario, Canada (population 12 million). STUDY
DESIGN: The Ontario Cancer Registry is an administrative database that links all hospital records, pathology reports, and vital statistics for patients with a diagnosis of cancer. We used the Registry to identify and obtain information on all patients who underwent liver resection for metastatic CRC in calendar years 1996 to 2004. Pathology reports of the original CRC resection and subsequent liver resections were individually reviewed.
RESULTS: Eight hundred forty-one resections were performed at 43 centers across Ontario during the 9-year period, including wedge resection (n = 303; 36%); lobectomy (n = 466; 55%); and trisectionectomy (n = 72; 9%). Ninety-one percent and 54% of resections were performed at teaching and high-volume centers (> 80 resections), respectively. Most liver resections were performed more than 120 days after original CRC operation (672 of 841; 80%). Perioperative mortality was 3%. Unadjusted 1-, 3-, and 5-year survival after liver resection was 88%, 59%, and 43%, respectively. Survival was improved when resection was performed for fewer than 2 tumor nodules, at high-volume centers, or in the years 2001 to 2004.
CONCLUSIONS: Results in this population-based series are consistent with those of single-hospital series assessing longterm survival after liver resection for metastatic CRC. These findings support continued efforts to aggressively identify and resect CRC liver metastases.

Entities:  

Mesh:

Year:  2007        PMID: 17964443     DOI: 10.1016/j.jamcollsurg.2007.06.283

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  29 in total

1.  Complications following liver resection for colorectal metastases do not impact on longterm outcome.

Authors:  Tony C Pang; Calista Spiro; Tim Ramacciotti; Julian Choi; Martin Drummond; Edmund Sweeney; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2014-08-26       Impact factor: 3.647

2.  Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery.

Authors:  Nicholas G Csikesz; Jessica P Simons; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

3.  High volume and outcome after liver resection: surgeon or center?

Authors:  Robert W Eppsteiner; Nicholas G Csikesz; Jessica P Simons; Jennifer F Tseng; Shimul A Shah
Journal:  J Gastrointest Surg       Date:  2008-08-13       Impact factor: 3.452

4.  Surgeon volume metrics in laparoscopic cholecystectomy.

Authors:  Nicholas G Csikesz; Anand Singla; Melissa M Murphy; Jennifer F Tseng; Shimul A Shah
Journal:  Dig Dis Sci       Date:  2009-11-13       Impact factor: 3.199

Review 5.  A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases.

Authors:  Wei Liu; Qing-Kun Song; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2015-05-27       Impact factor: 2.571

6.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases.

Authors:  Yanxin Luo; Lei Wang; Chuangqi Chen; Dianke Chen; Meijin Huang; Yihua Huang; Junsheng Peng; Ping Lan; Ji Cui; Shirong Cai; Jianping Wang
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

Review 7.  Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases.

Authors:  Chad G Rusthoven; Tracey E Schefter
Journal:  Hepat Oncol       Date:  2013-12-20

Review 8.  Optimal management of colorectal liver metastases in older patients: a decision analysis.

Authors:  Simon Yang; Shabbir M H Alibhai; Erin D Kennedy; Abraham El-Sedfy; Matthew Dixon; Natalie Coburn; Alex Kiss; Calvin H L Law
Journal:  HPB (Oxford)       Date:  2014-06-24       Impact factor: 3.647

9.  Recent trends of hepatic resection in Canada: 1995-2004.

Authors:  Ryan J McColl; Xiaoqing You; William A Ghali; Gilaad Kaplan; Robert Myers; Elijah Dixon
Journal:  J Gastrointest Surg       Date:  2008-09-11       Impact factor: 3.452

10.  A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases.

Authors:  Oliver F Bathe; Scott Ernst; Francis R Sutherland; Elijah Dixon; Charles Butts; David Bigam; David Holland; Geoffrey A Porter; Jennifer Koppel; Scot Dowden
Journal:  BMC Cancer       Date:  2009-05-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.